Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZECEN, formally Jiangsu Zecheng Biotechnology, is a private Chinese in vitro diagnostics company focused on chemiluminescence immunoassay systems, related reagents, and clinical laboratory instruments. The company develops, manufactures, and sells fully automated CLIA analyzers, POCT chemiluminescence systems, biochemical analyzers, and assay menus spanning thyroid, oncology, hormone, infectious disease, cardiac, diabetes, and fertility testing. ZECEN also positions itself as an integrated supplier across the CLIA value chain, including reagents, instruments, magnetic microbeads, raw materials, and antibodies. In addition to selling branded diagnostic products, it offers OEM/ODM and CDMO services for IVD materials and assay development. Overall, the company appears to be a commercial-stage diagnostics manufacturer rather than a therapeutic biotech drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZECEN.